Author:
Powell Sharon K.,Kaloss Michele A.,Pinkstaff Anne,McKee Rebecca,Burimski Irina,Pensiero Michael,Otto Edward,Stemmer Willem P.C.,Soong Nay-Wei
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference20 articles.
1. Braas, G., Searle, P.F., Slater, N.K.H. & Lyddiatt, A. Strategies for the isolation and purification of retroviral vectors for gene therapy. Bioseparation 6, 211– 228 (1996).
2. Friedmann, T. & Yee, J.-K. Pseudotyped retroviral vectors for studies of human gene therapy. Nat. Med. 6, 275–277 (1995).
3. Burns, J.C., Friedmann, T., Driever, W., Burrascano, M. & Yee, J.-K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high tier and efficient transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033– 8037 (1993).
4. Green, N. et al. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78, 6023– 6027 (1981).
5. Hunter, E. & Swanstrom, R. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187–253 (1990).